Table of Contents
Chapter 1. Global Continuous Glucose Monitoring Systems Market Executive Summary
1.1. Global Continuous Glucose Monitoring Systems Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Component
1.3.2. By Demography
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Continuous Glucose Monitoring Systems Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Continuous Glucose Monitoring Systems Market Dynamics
3.1. Market Drivers
3.1.1. Growth & Innovations in Medical Device Industry
3.1.2. Rise in Prevalence of Diabetes
3.1.3. Increase in Geriatric Population
3.2. Market Challenges
3.2.1. High Costs of CGMs
3.2.2. Regulatory and Reimbursement Issues
3.3. Market Opportunities
3.3.1. Advancements in R&D
3.3.2. Growing Demand in Emerging Markets
3.3.3. Increasing Awareness and Adoption
Chapter 4. Global Continuous Glucose Monitoring Systems Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Continuous Glucose Monitoring Systems Market Size & Forecasts by Component 2022-2032
5.1. Segment Dashboard
5.2. Global Continuous Glucose Monitoring Systems Market: Component Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Sensors
5.2.2. Transmitters & Receivers
Chapter 6. Global Continuous Glucose Monitoring Systems Market Size & Forecasts by Demography 2022-2032
6.1. Segment Dashboard
6.2. Global Continuous Glucose Monitoring Systems Market: Demography Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Child Population (<=14 years)
6.2.2. Adult Population (>14 years)
Chapter 7. Global Continuous Glucose Monitoring Systems Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Continuous Glucose Monitoring Systems Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Hospitals & Clinics
7.2.2. Home Healthcare
7.2.3. Others
Chapter 8. Global Continuous Glucose Monitoring Systems Market Size & Forecasts by Region 2022-2032
8.1. North America Continuous Glucose Monitoring Systems Market
8.1.1. U.S. Continuous Glucose Monitoring Systems Market
8.1.1.1. Component breakdown size & forecasts, 2022-2032
8.1.1.2. Demography breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Continuous Glucose Monitoring Systems Market
8.2. Europe Continuous Glucose Monitoring Systems Market
8.2.1. U.K. Continuous Glucose Monitoring Systems Market
8.2.2. Germany Continuous Glucose Monitoring Systems Market
8.2.3. France Continuous Glucose Monitoring Systems Market
8.2.4. Spain Continuous Glucose Monitoring Systems Market
8.2.5. Italy Continuous Glucose Monitoring Systems Market
8.2.6. Rest of Europe Continuous Glucose Monitoring Systems Market
8.3. Asia-Pacific Continuous Glucose Monitoring Systems Market
8.3.1. China Continuous Glucose Monitoring Systems Market
8.3.2. India Continuous Glucose Monitoring Systems Market
8.3.3. Japan Continuous Glucose Monitoring Systems Market
8.3.4. Australia Continuous Glucose Monitoring Systems Market
8.3.5. South Korea Continuous Glucose Monitoring Systems Market
8.3.6. Rest of Asia Pacific Continuous Glucose Monitoring Systems Market
8.4. Latin America Continuous Glucose Monitoring Systems Market
8.4.1. Brazil Continuous Glucose Monitoring Systems Market
8.4.2. Mexico Continuous Glucose Monitoring Systems Market
8.4.3. Rest of Latin America Continuous Glucose Monitoring Systems Market
8.5. Middle East & Africa Continuous Glucose Monitoring Systems Market
8.5.1. Saudi Arabia Continuous Glucose Monitoring Systems Market
8.5.2. South Africa Continuous Glucose Monitoring Systems Market
8.5.3. Rest of Middle East & Africa Continuous Glucose Monitoring Systems Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. A. Menarini Diagnostics S.r.l
9.1.2. Abbott Laboratories
9.1.3. DexCom, Inc.
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffman-La Roche Ltd
9.3.2. GlySens Incorporated
9.3.3. Johnson & Johnson
9.3.4. Medtronic plc
9.3.5. Novo Nordisk A/S
9.3.6. Senseonics
9.3.7. Ypsomed AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes